Progress in solving the sex hormone paradox in pulmonary hypertension.
about
The emerging role of AMPK in the regulation of breathing and oxygen supplySTAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspectivePulmonary Arterial Hypertension and the Sex Hormone Paradox.Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular functionRegulation and function of miR-214 in pulmonary arterial hypertension.Estrogen receptor-dependent attenuation of hypoxia-induced changes in the lung genome of pulmonary hypertension rats.Sex differences in pulmonary vascular control: focus on the nitric oxide pathwayDeletion of STAT5a/b in vascular smooth muscle abrogates the male bias in hypoxic pulmonary hypertension in mice: implications in the human disease.Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.Right ventricular sex differences in patients with idiopathic pulmonary arterial hypertension characterised by magnetic resonance imaging: pair-matched case controlled study.Role of epithelial sodium channels in the regulation of lung fluid homeostasisEET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.Hypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension.Cyp2c44 gene disruption exacerbated pulmonary hypertension and heart failure in female but not male micePrognostic Factors in Patients With Pulmonary Hypertension-A Nationwide Cohort Study.Discerning functional hierarchies of microRNAs in pulmonary hypertension.Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities.Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia.Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.Sex-specific cardiopulmonary exercise testing parameters as predictors in patients with idiopathic pulmonary arterial hypertension.Sex-specific cardiopulmonary exercise testing indices related to hemodynamics in idiopathic pulmonary arterial hypertension.Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.AMP-activated protein kinase inhibits Kv 1.5 channel currents of pulmonary arterial myocytes in response to hypoxia and inhibition of mitochondrial oxidative phosphorylation.17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research.Update on novel targets and potential treatment avenues in pulmonary hypertension.The right ventricle and pulmonary hypertension.Toward Harnessing Sex Steroid Signaling as a Therapeutic Target in Pulmonary Arterial Hypertension.Hypoxia Up-regulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α Dependent Manner.Secundum atrial septal defect is associated with reduced survival in adult men.Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.Vasodilator effects of dehydroepiandrosterone (DHEA) on fetal pulmonary circulation: An experimental study in pregnant sheep.Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen
P2860
Q28072485-57DC9DD5-A441-4CC0-B567-A3F9FDCF9208Q28081115-80EB3BBB-A5BF-491B-BDA3-A88885780633Q30241478-7E66C426-6BC6-4B46-BC77-CD3EB40D5E2DQ30277940-2FCA19B5-0F4F-42D8-8229-0F61CEC85572Q32884388-9670D3E6-EA83-4F83-81AA-18D045CD73FBQ33738546-29D5E2D4-766F-4D0C-A708-8444891F70ACQ33800175-B979AAFB-9FDF-47F4-853F-278EC85D6EFFQ35192830-1929B5A7-2916-463E-B8C6-FCFC72593403Q35574717-866AA8FE-7754-49D6-919F-D19B6BD32821Q35634008-25FFB832-3124-4B27-9F9F-926E760CFA48Q36345877-7082A3FB-5D30-429C-A630-87275DF097FDQ36382133-B5780F5E-F19D-41E1-B6E3-74EC70D78035Q36568290-73502AB7-8940-4E5C-A614-149302133C84Q37248337-9A89BD78-3361-44E6-BCAB-49E06B816D44Q37364426-ECA125BC-FF60-426C-BD60-D8BEA4B8B5DCQ37677437-79E89FC9-29BA-489E-9767-5AD75EC81C63Q37705261-3C038DE1-7FED-40B8-87DB-D4FE0D02F5D3Q38585146-B64837D6-B662-43C6-9258-5711819E74B7Q38642429-E8EB21FC-8A77-4C4F-A309-D41ACF9264EBQ38752500-47F4B6CA-F41E-4B7F-B693-1C2124F9FAE3Q39044337-1838A3EB-3CDB-47FF-B25C-6F8443A9185DQ40591652-20E51404-89F6-4E58-847C-209FFFE80710Q41005568-3AEB3010-EEA9-40CA-A19F-0A687C70CAF2Q42356930-9111C971-814D-4F7F-909A-DA18B5165DD7Q42357121-BBAA1230-D907-4019-AAEB-2F5358D5DEBEQ42784219-193016FE-E2C5-474D-B015-4848D99B5E01Q45026577-D6856889-0160-42B9-94D0-BFF9416A83E7Q47768780-35AF97CC-2945-407B-8FE5-2990A4555348Q49374499-7A9841AF-2A74-4709-88D3-EADFC2DF4667Q51033118-9E7C9955-0A85-475C-9BF4-BE38284AB11DQ52746396-5B2E08AB-1089-4131-9635-884271B29FCDQ54977617-3012A6AB-6DED-4757-9491-F66802881842Q55449072-76BBA8CE-92D8-4023-961C-7ED7F6632356Q58699067-3AB7EBDF-3F2B-4A23-B4A7-73DEE207F8DD
P2860
Progress in solving the sex hormone paradox in pulmonary hypertension.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Progress in solving the sex hormone paradox in pulmonary hypertension.
@en
type
label
Progress in solving the sex hormone paradox in pulmonary hypertension.
@en
prefLabel
Progress in solving the sex hormone paradox in pulmonary hypertension.
@en
P2093
P2860
P1476
Progress in solving the sex hormone paradox in pulmonary hypertension.
@en
P2093
Irina Petrache
Rubin M Tuder
P2860
P356
10.1152/AJPLUNG.00337.2013
P577
2014-05-09T00:00:00Z